Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlook

RL Yu, RM Wu - Frontiers in aging neuroscience, 2022 - frontiersin.org
Mild cognitive impairment (MCI) is one of the common non-motor symptoms in patients with
Parkinson's disease (PD). MCI is the transition stage between normal aging and full-blown …

A systematic review and meta‐analysis of respiratory dysfunction in Parkinson's disease

L McMahon, C Blake, O Lennon - European Journal of …, 2023 - Wiley Online Library
Abstract Introduction Respiratory dysfunction in Parkinson's disease (PD) is common and
associated with increased hospital admission and mortality rates. Central and peripheral …

[HTML][HTML] COVID-19: an early review of its global impact and considerations for Parkinson's disease patient care

R Bhidayasiri, S Virameteekul, JM Kim… - Journal of movement …, 2020 - ncbi.nlm.nih.gov
While many infectious disorders are unknown to most neurologists, COVID-19 is very
different. It has impacted neurologists and other health care workers, not only in our …

Prevalence of non‐motor symptoms and non‐motor fluctuations in Parkinson's disease using the MDS‐NMS

C Rodriguez‐Blazquez, A Schrag… - Movement Disorders …, 2021 - Wiley Online Library
Background Non‐motor symptoms (NMS) are frequent in Parkinson's disease (PD).
Objectives To estimate the prevalence of NMS and of non‐motor fluctuations (NMF) using …

Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease

S Basaia, F Agosta, A Francia, C Cividini… - npj Parkinson's …, 2022 - nature.com
Parkinson's disease (PD) patients can be classified in tremor-dominant (TD) and postural-
instability-and-gait-disorder (PIGD) motor subtypes. PIGD represents a more aggressive …

Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis

K Longardner, BA Wright, A Alakkas, H You, R Xu… - Plos one, 2023 - journals.plos.org
Background Parkinson disease (PD) psychosis (PDP) is a disabling non-motor symptom.
Pharmacologic treatment is limited to pimavanserin, quetiapine, and clozapine, which do not …

Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia

VE Georgakopoulou, A Gkoufa… - Medicine …, 2023 - spandidos-publications.com
Patients with Parkinson's disease (PD) and coronavirus disease 2019 (COVID‑19)‑
associated pneumonia present, according to the literature, high mortality rates due to the …

[HTML][HTML] Increased mortality in young-onset Parkinson's disease

E Hustad, TÅ Myklebust, S Gulati… - Journal of movement …, 2021 - ncbi.nlm.nih.gov
Objective Few studies have followed Parkinson's disease (PD) patients from the time of
diagnosis to the date of death. This study compared mortality in the Trondheim PD cohort to …

fNIRS-based brain state transition features to signify functional degeneration after Parkinson's disease

J Lu, Y Wang, Z Shu, X Zhang, J Wang… - Journal of Neural …, 2022 - iopscience.iop.org
Objective. Parkinson's disease (PD) is a common neurodegenerative brain disorder, and
early diagnosis is of vital importance for treatment. Existing methods are mainly focused on …

[HTML][HTML] Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms

S Zhang, Y Ma - World Journal of Psychiatry, 2022 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second most common neurodegenerative disease.
Psychosis is one of the common psychiatric presentations in the natural course of PD. PD …